category,datetime,headline,id,image,related,source,summary,url
company,1768942800,Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th,138190422,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,VRTX,Yahoo,"BOSTON, January 20, 2026--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth quarter and full year 2025 financial results on Thursday, February 12, 2026, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International) and reference the ""Vertex Pharmaceuticals Fourth Quarter 2025 Earnings Call.""",https://finnhub.io/api/news?id=3331edde8c5b81cddbeb755c4862d2c30cc29a264397ac3a882f9ed7ae85b315
company,1768879876,Unpacking Q3 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks,138186518,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,VRTX,Yahoo,The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Letâ€™s take a look at how Vertex Pharmaceuticals (NASDAQ:VRTX) and the rest of the therapeutics stocks fared in Q3.,https://finnhub.io/api/news?id=18bfda0135a2aa54d03b89eec3fd6cc064a0749018283b2ee59ddfa87c8c2ffa
